HLB Therapeutics loses final Supreme Court bid over South Korean vaccine-cartel fine
HLB Therapeutics has lost its final appeal against South Korea’s antitrust regulator involving its role in a massive public sector vaccine procurement cartel, a ruling that validates the watchdog's crackdown and...To view the full article, register now.
Already a subscriber? Click here to view full article